Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 5 de 5
1.
Mol Immunol ; 140: 136-143, 2021 12.
Article En | MEDLINE | ID: mdl-34710721

Host innate immune responses to tuberculosis are poorly explored. Recent findings emphasize the importance of innate cells in working against Mycobacterium tuberculosis, the etiologic agent of this deadly disease. In this study we have tried to learn the role of neutrophils in building up immunity against this pathogen during therapy. We isolated neutrophils from peripheral blood of healthy volunteers and pulmonary tuberculosis patients at different phases of their treatment and cultured them withtoll like receptor ligands overnight. Toll like receptor 2 and 4 expression on neutrophils was analyzed using flow cytometry. The supernatants were used to measure cytokines. We found that in tuberculosis patients, expression of TLR2, a proven receptor of Mycobacterium tuberculosis on neutrophils, was increased throughout the duration of therapy (measured at diagnosis, second month and sixth month of therapy). This demonstrates that TLR2 expression is altered as a result of treatment, but not TLR4. Also, the chemokines IL-8 and MIP1α showed a 'dip and raise' fashion as the therapy proceeded. Even though the increase in the pro-inflammatory cytokine secretion by neutrophils seen at the end of therapy is not as expected, it definitely increases our understanding on the function of these cells during TB disease and its resolution and opens new direction in neutrophil research.


Cytokines/metabolism , Neutrophils/metabolism , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism , Tuberculosis, Pulmonary/metabolism , Adult , Chemokine CCL3/metabolism , Female , Fluorescence , Humans , Interleukin-8/metabolism , Longitudinal Studies , Male , Tuberculosis, Pulmonary/drug therapy , Tumor Necrosis Factor-alpha/metabolism , Young Adult
2.
J Med Virol ; 83(5): 760-7, 2011 May.
Article En | MEDLINE | ID: mdl-21412785

The presence of distinct viral variants in different cells and secretions of the same person influences the transmission of HIV as well as the response to the host defense and to therapy. Sperm-associated virus is also a risk factor for sexual transmission of HIV. Characterization of the C2-V3 region of HIV1C env gene by the Heteroduplex Mobility Assay (HMA) and sequencing demonstrated the presence of distinct variants in the peripheral blood mononuclear cells (PBMCs) and the sperm of the same individual (n = 6). The translated amino acid sequences of HIV variants in the PBMCs of all the study participants (n = 12) and spermatozoa of the six participants characterized showed the presence of distinct variants with different numbers of N-linked glycosylation (NLG) sites. Infectivity of PBMCs of these persons by co-culture with PBMCs from healthy individuals as detected by the p24 levels in the culture supernatant did not show a correlation with the blood plasma viral load. Interestingly, the infectivity of the sperm samples from four of the five individuals showed positive correlation with the viral load in seminal plasma. The study suggests the presence of distinct viral variants in the sperm and PBMCs of the same person with differential infectivity, and the NLG sites may be associated with the affinity of HIV to receptor/co-receptor usages as well as affinity toward neutralizing antibodies which may influence the risk of sperm associated virus in sexual transmission of HIV and transmit the virus further to distal cells.


Blood/virology , HIV Infections/virology , HIV-1/genetics , HIV-1/isolation & purification , Polymorphism, Genetic , Spermatozoa/virology , Amino Acid Sequence , Coculture Techniques , Glycosylation , HIV Core Protein p24/biosynthesis , HIV-1/classification , Heteroduplex Analysis , Humans , Leukocytes, Mononuclear/virology , Male , Molecular Sequence Data , Mutation, Missense , Proviruses/classification , Proviruses/genetics , Proviruses/isolation & purification , Sequence Alignment , Sequence Analysis, DNA , env Gene Products, Human Immunodeficiency Virus/genetics
3.
Gynecol Endocrinol ; 26(12): 874-82, 2010 Dec.
Article En | MEDLINE | ID: mdl-20500101

Obesity and hyperandrogenaemia are key features of polycystic ovary syndrome (PCOS). The aim of this study was to investigate whether leptin and androgens are associated with obesity in PCOS subjects and identify whether there exist any genetic alterations in leptin gene in women with PCOS. The results reveal that leptin levels are elevated in women with PCOS and associate with BMI. However, irrespective of the obesity status leptin levels are higher in PCOS cases indicating that increased BMI/obesity may not be the only factor contributing to elevated levels of leptin. With regard to testosterone and androstenedione, the levels were increased in obese individuals irrespective of PCOS status. No correlation between leptin and androstenedione or testosterone was observed in controls and PCOS subjects. The single-nucleotide polymorphism G19A detected in the untranslated exon 1 of leptin gene was not associated with PCOS and does not contribute to elevated levels of leptin. The results overall suggest that androgen and leptin levels are increased in PCOS and obesity. It demonstrates that obesity is a confounding factor for hyperandrogenaemia irrespective of their PCOS status. The study rules out role of obesity status and leptin genotype in increase in leptin levels observed in PCOS cases.


Androstenedione/blood , Leptin/blood , Obesity/blood , Polycystic Ovary Syndrome/blood , Testosterone/blood , Adult , DNA/chemistry , DNA/genetics , Female , Genotype , Humans , Leptin/genetics , Linear Models , Obesity/genetics , Polycystic Ovary Syndrome/genetics , Polymerase Chain Reaction , Polymorphism, Single Nucleotide , Sequence Analysis, DNA
4.
Mol Diagn Ther ; 13(1): 49-58, 2009.
Article En | MEDLINE | ID: mdl-19351215

BACKGROUND AND OBJECTIVES: Polymorphisms of the N-acetyltransferase 2 gene (NAT2) vary remarkably between populations of different ethnic origin. The NAT2 gene determines the individual's acetylator status to metabolize drugs and xenobiotics, influencing their toxicity and efficacy profiles. This study investigates the frequencies of the most commonly studied NAT2 polymorphisms in a southwestern Indian population and compares these with those reported in other Indian and world populations. The association of these polymorphisms with plasma isoniazid concentrations in a cohort of tuberculosis patients has also been investigated. METHODS: NAT2 genotyping of 201 subjects was carried out by PCR-restriction fragment length polymorphism (PCR-RFLP) analysis and DNA sequencing. Acetylation phenotypes were predicted from NAT2 genotypes. The association of NAT2 genotypes with plasma isoniazid concentrations was determined by measuring the plasma levels in tuberculosis patients at different time points using reverse-phase high-performance liquid chromatography (HPLC). RESULTS: The predominant alleles found in this study population were NAT2*5B and NAT2*6A, while NAT2*5B/*6A and NAT2*6A/*6A were the most frequent genotypes; the frequency varied widely from other reported studies in the Indian population. The distribution of slow, intermediate, and fast acetylators was 55%, 32%, and 13%, respectively. We observed relatively higher plasma concentrations of isoniazid in our patients than those reported in other similar studies, and they correlated well with the NAT2 genotypes. CONCLUSION: The results suggested high variation in the frequencies of NAT2 alleles and genotypes within Indian populations, which influence plasma isoniazid concentrations. Further studies of the relationship between NAT2 genotypes and adverse drug events are required to make genotyping a helpful tool for optimizing the isoniazid therapeutic response and minimizing adverse drug reactions, particularly in countries with a high burden of tuberculosis.


Antitubercular Agents/blood , Arylamine N-Acetyltransferase/genetics , Isoniazid/blood , Tuberculosis, Pulmonary/genetics , Acetylation , Adult , Amplified Fragment Length Polymorphism Analysis , Antitubercular Agents/pharmacokinetics , Arylamine N-Acetyltransferase/metabolism , Cohort Studies , Female , Humans , Inactivation, Metabolic , India , Isoniazid/pharmacokinetics , Male , Phenotype , Polymerase Chain Reaction , Tuberculosis, Pulmonary/blood , Tuberculosis, Pulmonary/drug therapy
5.
Fertil Steril ; 92(2): 653-9, 2009 Aug.
Article En | MEDLINE | ID: mdl-18725155

OBJECTIVE: To analyze promoter regions of CYP11A1 and CYP17 for putative variations in a defined group of women with polycystic ovary syndrome (PCOS) and to study their association with androgen levels. DESIGN: Retrospective study. SETTING: A secondary referral center for infertility at National Institute for Research in Reproductive Health, Mumbai, India. PATIENT(S): One hundred women whose condition was diagnosed on the basis of the Rotterdam consensus were compared against 100 age-matched controls. INTERVENTION(S): A single sample of blood was collected after overnight fast on day 3 of the menstrual cycle. MAIN OUTCOME MEASURE(S): Plasma levels of T, androstenedione, 17alpha-hydroxyprogesterone, and DHEAS and nucleotide sequence of promoter regions of CYP11A1 and CYP17 genes. RESULT(S): Polymorphisms in promoter regions of the two key androgen-regulating genes, CYP11A1 and CYP17, were found to be significantly associated with T levels in the cohort of well-characterized PCOS cases as compared with controls. The significance was greater in the PCOS cases with both the polymorphisms. CONCLUSION(S): Our study carried out in a defined group of Indian women with PCOS suggests for the first time an individual, as well as combined, association of polymorphisms in CYP11A1 and CYP17 promoters with T levels.


Cholesterol Side-Chain Cleavage Enzyme/genetics , Hydroxysteroid Dehydrogenases/genetics , Hyperandrogenism/epidemiology , Hyperandrogenism/genetics , Polycystic Ovary Syndrome/epidemiology , Polycystic Ovary Syndrome/genetics , Polymorphism, Single Nucleotide/genetics , Steroid 17-alpha-Hydroxylase/genetics , Comorbidity , Female , Genetic Predisposition to Disease/genetics , Humans , Incidence , India/epidemiology , Promoter Regions, Genetic/genetics , Risk Assessment , Risk Factors , Young Adult
...